Vivo Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-158,310
Closed -$21.6M 69
2020
Q3
$21.6M Hold
158,310
1.25% 19
2020
Q2
$15.3M Sell
158,310
-175,311
-53% -$14.6M 1.1% 25
2020
Q1
$15.6M Buy
+333,621
New +$21.4M 1.42% 22

Vivo Capital's MYOK Position: Q4 2020 in Review

Vivo Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 158,310 shares — an estimated $21.6M sold.

Vivo Capital first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $21.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Vivo Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Vivo Capital sold 158,310 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $21.6M.
  • Vivo Capital first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Vivo Capital's MyoKardia, Inc. Common Stock position peaked at $21.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Vivo Capital's 13F filing for Q4 2020, filed 16 Feb 2021.